AKKARAJU SRINIVAS
Insider CIK 1253170 · WHRT 10% owner · SGEN Director · MEIP 10% owner · ALIM 10% owner · ICPT Director · LIFE Director · HSGX 10% owner · NGNE 10% owner · KDNY Director · ZSPH Director · PRNB Director · VSAR Director, 10% owner · MIRN 10% owner · DRTX 10% owner · SYRS Director · ACRS 10% owner · VTVT Director, 10% owner · SRRK Director, 10% owner · KLRS Director, 10% owner · GRPH 10% owner · JYAC Director, 10% owner · ALMS Director · MLYS Director, 10% owner · CRGX 10% owner · GEVA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding Corp | P Buy | 2026-10-26 | 2026-10-27 | 97,982 | $41.59 | $4.08M | 723,020 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2026-10-26 | 2026-10-27 | 48,988 | $41.59 | $2.04M | 6,380,517 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2026-10-23 | 2026-10-27 | 1,000 | $41.82 | $41.8K | 625,038 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2026-10-23 | 2026-10-27 | 500 | $41.82 | $20.9K | 6,331,529 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2026-10-23 | 2026-10-27 | 94,000 | $41.31 | $3.88M | 624,038 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2026-10-23 | 2026-10-27 | 47,000 | $41.31 | $1.94M | 6,331,029 | SEC↗ |
| ALMS ALUMIS INC. | S Sale | 2026-09-08 | 2026-09-09 | 48,065 | $10.55 | $507.1K | 2,025,493 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-09-08 | 2026-09-09 | 273,290 | $10.63 | $2.91M | 2,298,783 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-09-08 | 2026-09-09 | 273,291 | $10.63 | $2.91M | 4,937,026 | SEC↗ |
| ALMS ALUMIS INC. | S Sale | 2026-09-08 | 2026-09-09 | 48,066 | $10.55 | $507.1K | 4,663,735 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-09-08 | 2026-09-09 | 273,290 | $10.63 | $2.90M | 2,298,783 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-09-08 | 2026-09-09 | 273,291 | $10.63 | $2.90M | 4,937,026 | SEC↗ |
| ALMS ALUMIS INC. | S Sale | 2026-09-08 | 2026-09-09 | 48,065 | $10.55 | $507.0K | 2,025,493 | SEC↗ |
| ALMS ALUMIS INC. | S Sale | 2026-09-08 | 2026-09-09 | 48,066 | $10.55 | $507.0K | 4,663,735 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-09-04 | 2026-09-09 | 220,070 | $11.17 | $2.46M | 4,711,801 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-09-04 | 2026-09-09 | 220,070 | $11.17 | $2.46M | 2,073,558 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-09-04 | 2026-09-09 | 220,070 | $11.17 | $2.46M | 2,073,558 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-09-04 | 2026-09-09 | 220,070 | $11.17 | $2.46M | 4,711,801 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2026-06-30 | 2026-07-02 | 15,528 | — | $0 | 15,528 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2026-06-30 | 2026-07-02 | 3,553 | — | $0 | 3,553 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2026-06-26 | 2026-06-29 | 6,000 | $35.08 | $210.5K | 16,983 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2026-06-04 | 2026-06-08 | 4,310 | — | $0 | 4,310 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2026-06-04 | 2026-06-08 | 6,839 | — | $0 | 27,971 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2026-06-03 | 2026-06-04 | 9,000 | — | $0 | 9,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | J Other | 2026-05-20 | 2026-05-22 | 14,937 | — | $0 | 14,937 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | P Buy | 2026-05-20 | 2026-05-22 | 244,300 | $4.83 | $1.18M | 2,224,147 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | J Other | 2026-05-20 | 2026-05-22 | 66,906 | — | $0 | 10,657,028 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | J Other | 2026-05-20 | 2026-05-22 | 4,471 | — | $0 | 19,408 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-02-19 | 2026-02-20 | 8,300 | — | $0 | 8,300 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-02-19 | 2026-02-20 | 6,200 | — | $0 | 6,200 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2026-01-09 | 2026-01-13 | 588,235 | $17.00 | $10.00M | 1,853,488 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award | 2025-12-22 | 2025-12-22 | 1,500,000 | $10.00 | $15.00M | 1,500,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | P Buy | 2025-12-18 | 2026-02-17 | 479,847 | $10.42 | $5.00M | 1,979,847 | SEC↗ |
| SRRK Scholar Rock Holding Corp | X Exercise deriv | 2025-12-12 | 2025-12-16 | 1,064,804 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | X Exercise | 2025-12-12 | 2025-12-16 | 1,064,804 | $7.35 | $7.83M | 6,367,614 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-12-05 | 2025-12-09 | 64,969 | $8.95 | $581.5K | 1,143,845 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-12-05 | 2025-12-09 | 51,380 | $10.73 | $551.3K | 1,265,253 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-12-05 | 2025-12-09 | 70,028 | $10.01 | $701.0K | 1,213,873 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-12-04 | 2025-12-04 | 66,027 | $8.18 | $540.1K | 1,078,876 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-12-03 | 2025-12-04 | 100,000 | $7.75 | $775.0K | 1,012,849 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-12-02 | 2025-12-04 | 96,000 | $7.55 | $724.8K | 912,849 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-12-01 | 2025-12-01 | 86,350 | $7.46 | $644.2K | 816,849 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-28 | 2025-12-01 | 38,702 | $7.64 | $295.7K | 730,499 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-26 | 2025-12-01 | 48,537 | $7.64 | $370.8K | 691,797 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-20 | 2025-11-24 | 125,743 | $7.20 | $905.3K | 643,260 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-19 | 2025-11-19 | 137,772 | $6.56 | $903.8K | 517,517 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-18 | 2025-11-19 | 102,652 | $6.05 | $621.0K | 379,745 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-17 | 2025-11-19 | 914 | $5.51 | $5.0K | 277,093 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-11-13 | 2025-11-17 | 276,179 | $5.25 | $1.45M | 276,179 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2025-10-07 | 2025-12-16 | 12,400 | $40.18 | $498.2K | 525,635 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2025-10-07 | 2025-12-16 | 12,796 | $39.31 | $503.0K | 513,235 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2025-10-07 | 2025-12-16 | 4,403 | $40.97 | $180.4K | 530,038 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2025-10-06 | 2025-10-07 | 80,863 | $38.68 | $3.13M | 486,691 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2025-10-06 | 2025-10-07 | 13,748 | $39.52 | $543.3K | 500,439 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2025-10-06 | 2025-10-07 | 18,414 | $37.89 | $697.7K | 405,828 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2025-10-03 | 2025-10-07 | 11,011 | $35.61 | $392.1K | 11,011 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2025-10-03 | 2025-10-07 | 56,703 | $36.74 | $2.08M | 67,714 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2025-10-03 | 2025-10-07 | 319,700 | $37.42 | $11.96M | 387,414 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2025-09-22 | 2025-09-25 | 983,214 | — | $0 | 983,214 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2025-09-22 | 2025-09-25 | 877,214 | — | $0 | 877,214 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award | 2025-09-22 | 2025-09-25 | 106,000 | $15.27 | $1.62M | 106,000 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2025-09-04 | 2025-09-08 | 588,235 | $25.50 | $15.00M | 588,235 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2025-09-03 | 2025-09-05 | 655,523 | — | $0 | 655,523 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2025-09-03 | 2025-09-05 | 655,523 | — | $0 | 1,548,101 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-07-30 | 2025-08-01 | 49,800 | — | $0 | 49,800 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 4,000 | $16.59 | $66.4K | 10,983 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2025-05-22 | 2025-05-23 | 9,206 | — | $0 | 9,206 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2025-05-22 | 2025-05-23 | 7,632 | — | $0 | 21,132 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2025-05-21 | 2025-05-23 | 1,214,582 | — | $0 | 4,801,370 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-05-05 | 2025-05-06 | 138,368 | $4.58 | $633.7K | 3,564,786 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-05-05 | 2025-05-06 | 22,002 | $5.27 | $116.0K | 3,586,788 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2025-05-02 | 2025-05-06 | 159,920 | $4.55 | $727.6K | 3,426,418 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award deriv | 2025-04-10 | 2025-04-11 | 18,000 | — | $0 | 18,000 | SEC↗ |
| KLRS Kalaris Therapeutics, Inc. | A Award | 2025-03-18 | 2025-03-18 | 11,444,503 | — | $0 | 11,444,503 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2025-03-13 | 2025-03-17 | 600,000 | $13.50 | $8.10M | 5,674,916 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2025-02-13 | 2025-02-24 | 32,900 | — | $0 | 32,900 | SEC↗ |
| NGNE Neurogene Inc. | P Buy | 2024-11-26 | 2024-11-27 | 20,748 | $24.91 | $516.8K | 1,689,105 | SEC↗ |
| NGNE Neurogene Inc. | P Buy | 2024-11-26 | 2024-11-27 | 10,803 | $26.01 | $281.0K | 1,699,908 | SEC↗ |
| NGNE Neurogene Inc. | P Buy | 2024-11-26 | 2024-11-27 | 15,219 | $26.73 | $406.8K | 1,715,127 | SEC↗ |
| NGNE Neurogene Inc. | P Buy | 2024-11-26 | 2024-11-27 | 2,000 | $27.50 | $55.0K | 1,717,127 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2024-10-07 | 2024-10-07 | 510,000 | $30.00 | $15.30M | 5,768,609 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2024-10-07 | 2024-10-07 | 510,000 | $27.50 | $14.03M | 6,278,609 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2024-10-07 | 2024-10-07 | 155,713 | $32.50 | $5.06M | 5,612,896 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-09-16 | 2024-09-18 | 2,667 | — | $0 | 2,667 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-09-16 | 2024-09-18 | 2,667 | — | $0 | 9,333 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion deriv | 2024-07-01 | 2024-07-01 | 1,703,998 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer | 2024-07-01 | 2024-07-01 | 1,703,998 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2024-07-01 | 2024-07-01 | 1,703,998 | — | $0 | 1,703,998 | SEC↗ |
| ALMS ALUMIS INC. | C Conversion | 2024-07-01 | 2024-07-01 | 1,703,998 | — | $0 | 1,703,998 | SEC↗ |
| ALMS ALUMIS INC. | P Buy | 2024-07-01 | 2024-08-27 | 1,562,500 | $16.00 | $25.00M | 3,266,498 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2024-06-27 | 2024-07-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2024-06-27 | 2024-07-01 | 13,500 | — | $0 | 13,500 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2024-06-25 | 2025-04-24 | 2,250 | $17.22 | $38.7K | 6,000 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2024-06-25 | 2025-04-24 | 983 | $17.22 | $16.9K | 6,983 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 4,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-06-01 | 2024-06-04 | 4,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-06-01 | 2024-06-04 | 4,000 | — | $0 | 6,666 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | P Buy | 2024-05-30 | 2024-06-03 | 294,000 | $17.00 | $5.00M | 4,415,689 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2024-05-22 | 2024-05-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2024-03-05 | 2024-12-06 | 58,885 | — | $0 | 892,578 | SEC↗ |
| VTVT vTv Therapeutics Inc. | D To issuer | 2024-03-05 | 2024-12-06 | 58,836 | — | $0 | 206,784 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2024-02-27 | 2024-06-13 | 3,750 | — | $0 | 3,750 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award deriv | 2024-02-27 | 2024-02-29 | 833,693 | $11.80 | $9.84M | 833,693 | SEC↗ |
| VTVT vTv Therapeutics Inc. | A Award | 2024-02-27 | 2024-02-29 | 224,732 | $11.81 | $2.65M | 265,620 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2024-02-12 | 2024-02-14 | 555,555 | $13.50 | $7.50M | 5,074,916 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2023-12-21 | 2023-12-26 | 904,977 | $4.42 | $4.00M | 1,786,427 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion deriv | 2023-11-14 | 2023-11-16 | 884,400 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion deriv | 2023-11-14 | 2023-11-16 | 663,300 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion deriv | 2023-11-14 | 2023-11-16 | 1,833,623 | — | $0 | 0 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | C Conversion | 2023-11-14 | 2023-11-16 | 3,381,323 | — | $0 | 3,455,023 | SEC↗ |
| CRGX CARGO Therapeutics, Inc. | P Buy | 2023-11-14 | 2023-11-16 | 666,666 | $15.00 | $10.00M | 4,121,689 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 1,750 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,174 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,748 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,036 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 1,598 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 2,966 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 275 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,547 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,790 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer deriv | 2023-11-08 | 2023-11-13 | 12,089 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | U Tender | 2023-11-08 | 2023-11-13 | 640,688 | $19.00 | $12.17M | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | D To issuer | 2023-11-08 | 2023-11-13 | 8,111 | $19.00 | $154.1K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | U Tender | 2023-11-08 | 2023-11-13 | 37,887 | $19.00 | $719.9K | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | P Buy | 2023-10-16 | 2023-10-18 | 2,189,781 | $6.85 | $15.00M | 6,788,609 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-09-16 | 2023-09-19 | 2,666 | — | $0 | 5,334 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-09-16 | 2023-09-19 | 2,666 | — | $0 | 2,666 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 13,300 | $26.12 | $347.4K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 23,522 | $25.23 | $593.5K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 5,948 | $23.19 | $137.9K | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer | 2023-08-11 | 2023-08-11 | 3,300 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | D To issuer | 2023-08-11 | 2023-08-11 | 5,161,888 | — | $0 | 0 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2023-06-21 | 2023-06-22 | 36,000 | — | $0 | 36,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise deriv | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 0 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | M Exercise | 2023-05-26 | 2023-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2023-05-24 | 2023-05-25 | 12,547 | — | $0 | 12,547 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2023-05-24 | 2023-05-25 | 8,111 | — | $0 | 45,998 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion deriv | 2023-02-14 | 2023-02-16 | 2,135,504 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion deriv | 2023-02-14 | 2023-02-16 | 1,446,357 | — | $0 | 0 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2023-02-14 | 2023-02-16 | 937,500 | $16.00 | $15.00M | 4,519,361 | SEC↗ |
| MLYS Mineralys Therapeutics, In | C Conversion | 2023-02-14 | 2023-02-16 | 3,581,861 | — | $0 | 3,581,861 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2023-02-09 | 2023-02-13 | 44,000 | — | $0 | 44,000 | SEC↗ |
| JYAC Jiya Acquisition Corp. | J Other deriv | 2022-09-23 | 2022-09-23 | 29,667 | — | $0 | 2,437,114 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 691,489 | — | $0 | 691,489 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 8,000 | — | $0 | 8,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2022-09-16 | 2023-04-20 | 691,489 | — | $0 | 881,450 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2022-09-16 | 2022-09-20 | 56,000 | — | $0 | 56,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | P Buy | 2022-05-27 | 2022-06-01 | 570,000 | $14.00 | $7.98M | 5,161,888 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2022-05-26 | 2022-05-31 | 13,300 | — | $0 | 13,300 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2022-05-26 | 2022-05-31 | 3,300 | — | $0 | 3,300 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2022-05-25 | 2022-05-27 | 12,790 | — | $0 | 12,790 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2022-05-25 | 2022-05-27 | 7,737 | — | $0 | 37,887 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-04-12 | 2022-04-13 | 350,000 | $4.08 | $1.43M | 8,459,314 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-04-11 | 2022-04-13 | 74,464 | $4.07 | $303.1K | 8,109,314 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-01-24 | 2022-01-25 | 23,000 | $8.70 | $200.1K | 8,034,850 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-01-21 | 2022-01-25 | 100,000 | $8.99 | $899.0K | 8,011,850 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-01-20 | 2022-01-21 | 43,105 | $8.92 | $384.5K | 7,911,850 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2022-01-19 | 2022-01-21 | 54,565 | $9.24 | $504.2K | 7,868,745 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-12-15 | 2021-12-20 | 22,329 | $10.19 | $227.5K | 7,814,180 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-11-22 | 2021-11-24 | 201,685 | $10.15 | $2.05M | 7,791,851 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | P Buy | 2021-11-15 | 2021-11-17 | 1,215,000 | $14.00 | $17.01M | 4,591,888 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-15 | 2021-10-15 | 2,300 | $12.49 | $28.7K | 7,590,166 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-14 | 2021-10-15 | 3,100 | $12.50 | $38.8K | 7,587,866 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-13 | 2021-10-15 | 45,400 | $13.22 | $600.2K | 7,584,766 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-08 | 2021-10-08 | 75,000 | $13.12 | $984.0K | 7,539,366 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-07 | 2021-10-08 | 9,021 | $14.94 | $134.8K | 7,464,366 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-10-06 | 2021-10-08 | 61,475 | $13.83 | $850.2K | 7,455,345 | SEC↗ |
| JYAC Jiya Acquisition Corp. | J Other deriv | 2021-09-23 | 2021-09-27 | 30,000 | — | $0 | 2,437,447 | SEC↗ |
| JYAC Jiya Acquisition Corp. | J Other deriv | 2021-09-23 | 2021-09-27 | 30,000 | — | $0 | 2,407,447 | SEC↗ |
| JYAC Jiya Acquisition Corp. | J Other deriv | 2021-08-26 | 2021-08-30 | 5,000 | — | $0 | 2,407,447 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | P Buy | 2021-08-18 | 2021-08-20 | 208,500 | $11.98 | $2.50M | 3,376,888 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 1,802,372 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 15,000,000 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 55,336 | — | $0 | 0 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 741,107 | — | $0 | 6,908,870 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 6,167,763 | — | $0 | 6,167,763 | SEC↗ |
| GRPH Graphite Bio, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 22,753 | — | $0 | 22,753 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 485,000 | $17.00 | $8.24M | 7,393,870 | SEC↗ |
| GRPH Graphite Bio, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 15,000 | $17.00 | $255.0K | 37,753 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| KDNY CHINOOK THERAPEUTICS, INC. | A Award deriv | 2021-06-04 | 2021-06-08 | 5,948 | — | $0 | 5,948 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2021-05-27 | 2021-06-01 | 12,089 | — | $0 | 12,089 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2021-05-27 | 2021-06-01 | 7,029 | — | $0 | 30,150 | SEC↗ |
| JYAC Jiya Acquisition Corp. | J Other deriv | 2021-04-13 | 2021-04-15 | 5,000 | — | $0 | 2,412,447 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | P Buy | 2021-03-12 | 2021-03-12 | 147,000 | $21.29 | $3.13M | 640,688 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | P Buy | 2021-03-10 | 2021-03-12 | 73,441 | $20.83 | $1.53M | 477,129 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | P Buy | 2021-03-10 | 2021-03-12 | 16,559 | $21.55 | $356.8K | 493,688 | SEC↗ |
| JYAC Jiya Acquisition Corp. | A Award | 2020-12-09 | 2020-12-11 | 7,041 | $10.00 | $70.4K | 507,041 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-12-08 | 2020-12-11 | 156,250 | — | $0 | 156,250 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2020-12-08 | 2020-12-11 | 625,000 | — | $0 | 1,899,616 | SEC↗ |
| JYAC Jiya Acquisition Corp. | A Award | 2020-11-23 | 2020-11-25 | 500,000 | $10.00 | $5.00M | 500,000 | SEC↗ |
| KDNY ADURO BIOTECH, INC. | A Award deriv | 2020-10-06 | 2020-10-07 | 23,522 | — | $0 | 23,522 | SEC↗ |
| KDNY ADURO BIOTECH, INC. | A Award | 2020-10-05 | 2020-10-07 | 3,168,388 | — | $0 | 3,168,388 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-08-18 | 2020-08-19 | 158,583 | $13.10 | $2.08M | 1,274,616 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-08-17 | 2020-08-19 | 744 | $13.00 | $9.7K | 1,433,199 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-07-01 | 2020-07-06 | 4,627 | $11.01 | $50.9K | 1,433,943 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-06-25 | 2020-06-25 | 54,972 | $11.15 | $612.9K | 1,438,570 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-06-24 | 2020-06-25 | 48,775 | $11.07 | $539.9K | 1,493,542 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-06-23 | 2020-06-25 | 50,953 | $11.11 | $566.1K | 1,542,317 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-06-11 | 2020-06-11 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2020-05-28 | 2020-06-01 | 2,966 | — | $0 | 2,966 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2020-05-28 | 2020-06-01 | 1,595 | — | $0 | 23,121 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2020-05-15 | 2020-05-19 | 3,171 | — | $0 | 3,171 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2020-05-15 | 2020-05-19 | 1,335 | — | $0 | 41,503 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2020-05-05 | 2020-05-07 | 8,500 | — | $0 | 9,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2020-05-05 | 2020-05-07 | 8,500 | $167.26 | $1.42M | 40,168 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2020-05-05 | 2020-05-07 | 8,500 | $20.06 | $170.5K | 48,668 | SEC↗ |
| ARAV Aravive, Inc. | P Buy | 2019-12-02 | 2019-12-02 | 133,333 | $7.50 | $1000.0K | 576,066 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2019-11-21 | 2019-11-22 | 12,558 | — | $0 | 4,942 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2019-11-21 | 2019-11-22 | 4,942 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2019-11-21 | 2019-11-22 | 12,558 | $119.51 | $1.50M | 40,168 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | S Sale | 2019-11-21 | 2019-11-22 | 4,942 | $120.46 | $595.3K | 40,168 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2019-11-21 | 2019-11-22 | 12,558 | $19.02 | $238.9K | 52,726 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2019-11-21 | 2019-11-22 | 4,942 | $19.02 | $94.0K | 45,110 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-09-12 | 2019-09-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | P Buy | 2019-08-28 | 2019-08-30 | 5,207 | $60.32 | $314.1K | 403,688 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-08-22 | 2019-08-22 | 1,180 | $64.30 | $75.9K | 398,481 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | P Buy | 2019-08-22 | 2019-08-23 | 1,180 | $64.30 | $75.9K | 398,481 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-08-21 | 2019-08-22 | 29,000 | $67.12 | $1.95M | 397,301 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | P Buy | 2019-08-21 | 2019-08-23 | 29,000 | $67.12 | $1.95M | 397,301 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-08-20 | 2019-08-22 | 37,604 | $65.85 | $2.48M | 368,301 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | P Buy | 2019-08-20 | 2019-08-23 | 37,604 | $65.85 | $2.48M | 368,301 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2019-06-20 | 2019-06-21 | 2,174 | — | $0 | 2,174 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-06-20 | 2019-06-21 | 1,570 | — | $0 | 21,526 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-06-11 | 2019-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2019-05-20 | 2019-05-22 | 7,038 | — | $0 | 7,038 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2019-05-20 | 2019-05-22 | 2,963 | — | $0 | 40,168 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2019-05-14 | 2019-05-14 | 119,760 | $83.50 | $10.00M | 330,697 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-04-25 | 2019-04-29 | 1,001 | — | $0 | 979 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise deriv | 2019-04-25 | 2019-04-29 | 2,499 | — | $0 | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-04-25 | 2019-04-29 | 2,499 | $21.50 | $53.7K | 18,955 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | M Exercise | 2019-04-25 | 2019-04-29 | 1,001 | $31.90 | $31.9K | 19,956 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy deriv | 2019-04-09 | 2019-04-11 | 133,333 | — | $0 | 133,333 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2019-04-09 | 2019-04-11 | 533,332 | $7.50 | $4.00M | 1,593,270 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | S Sale | 2019-02-19 | 2019-02-21 | 23,438 | $128.78 | $3.02M | 210,937 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-01-03 | 2019-01-07 | 4,688 | — | $0 | 4,688 | SEC↗ |
| ARAV Aravive, Inc. | A Award deriv | 2019-01-03 | 2019-01-07 | 4,688 | — | $0 | 4,688 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise deriv | 2018-10-30 | 2018-11-01 | 5,000 | — | $0 | 0 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | M Exercise | 2018-10-30 | 2018-11-01 | 5,000 | $8.38 | $41.9K | 37,205 | SEC↗ |
| ARAV Aravive, Inc. | A Award | 2018-10-12 | 2018-10-16 | 27,456 | — | $0 | 31,815 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion deriv | 2018-09-18 | 2018-09-20 | 208,480 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | P Buy | 2018-09-18 | 2018-09-20 | 175,000 | $17.00 | $2.98M | 383,480 | SEC↗ |
| PRNB Principia Biopharma Inc. | C Conversion | 2018-09-18 | 2018-09-20 | 208,480 | — | $0 | 208,480 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2018-09-13 | 2019-01-10 | 20,475 | — | $0 | 20,475 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award deriv | 2018-06-20 | 2018-06-22 | 2,748 | — | $0 | 2,748 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS, | A Award | 2018-06-20 | 2018-06-22 | 1,787 | — | $0 | 16,456 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-06-14 | 2018-06-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2018-06-13 | 2018-06-15 | 53,018 | $2.13 | $112.9K | 2,682,554 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2018-06-08 | 2018-06-08 | 231,580 | $2.00 | $463.2K | 2,629,536 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2018-06-07 | 2018-06-08 | 163,224 | $1.85 | $302.0K | 2,397,956 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2018-06-06 | 2018-06-08 | 660,681 | $1.74 | $1.15M | 2,234,732 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2018-05-18 | 2018-05-22 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2018-05-18 | 2018-05-22 | 3,700 | — | $0 | 32,205 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2018-04-05 | 2018-04-09 | 234,375 | $64.00 | $15.00M | 234,375 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2018-01-31 | 2018-02-02 | 209,424 | $9.55 | $2.00M | 1,059,938 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-12-20 | 2017-12-22 | 11,200 | — | $0 | 26,155 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2017-12-14 | 2017-12-14 | 26,600 | $8.99 | $239.1K | 830,494 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2017-12-13 | 2017-12-14 | 68,400 | $8.97 | $613.5K | 803,894 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2017-12-12 | 2017-12-14 | 14,774 | $9.40 | $138.9K | 735,494 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2017-12-05 | 2017-12-05 | 42,895 | $2.00 | $85.8K | 1,547,896 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2017-12-04 | 2017-12-05 | 513,872 | $2.21 | $1.14M | 1,505,001 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2017-12-01 | 2017-12-05 | 419,700 | $2.13 | $894.0K | 991,129 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2017-06-27 | 2017-06-29 | 2,036 | — | $0 | 2,036 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2017-06-27 | 2017-06-29 | 1,423 | — | $0 | 14,669 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-06-08 | 2017-09-22 | 22,000 | — | $0 | 22,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-06-08 | 2017-06-12 | 22,000 | — | $0 | 22,000 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2017-05-25 | 2017-06-06 | 6,850 | — | $0 | 6,850 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2017-05-25 | 2017-06-06 | 3,480 | — | $0 | 14,955 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2017-05-19 | 2017-05-23 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2017-05-19 | 2017-05-23 | 3,700 | — | $0 | 28,505 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2017-05-09 | 2017-05-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2017-03-24 | 2017-03-28 | 571,429 | $12.25 | $7.00M | 571,429 | SEC↗ |
| VSAR Versartis, Inc. | P Buy | 2016-10-03 | 2016-10-04 | 571,429 | $12.25 | $7.00M | 571,429 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2016-07-19 | 2016-07-21 | 1,598 | — | $0 | 1,598 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2016-07-19 | 2016-07-21 | 1,204 | — | $0 | 13,246 | SEC↗ |
| VSAR Versartis, Inc. | A Award deriv | 2016-06-14 | 2016-06-20 | 28,720 | — | $0 | 28,720 | SEC↗ |
| VSAR Versartis, Inc. | A Award | 2016-06-14 | 2016-06-20 | 6,900 | — | $0 | 11,475 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-05-24 | 2016-05-26 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award deriv | 2016-05-20 | 2016-05-24 | 9,260 | — | $0 | 9,260 | SEC↗ |
| SGEN SEATTLE GENETICS INC /WA | A Award | 2016-05-20 | 2016-05-24 | 3,700 | — | $0 | 24,805 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2016-05-13 | 2016-05-17 | 1,500 | — | $0 | 2,499 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2016-05-13 | 2016-05-17 | 1,500 | $21.50 | $32.3K | 12,042 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-01-27 | 2016-01-29 | 19,428 | — | $0 | 19,428 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 4,000 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 12,000 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer | 2015-12-17 | 2015-12-21 | 1,000 | $90.00 | $90.0K | 0 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award deriv | 2015-11-24 | 2015-11-27 | 1,750 | — | $0 | 1,750 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | A Award | 2015-11-24 | 2015-11-27 | 650 | — | $0 | 10,542 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise deriv | 2015-10-28 | 2015-10-30 | 1,250 | — | $0 | 3,999 | SEC↗ |
| ICPT INTERCEPT PHARMACEUTICALS | M Exercise | 2015-10-28 | 2015-10-30 | 1,250 | $21.50 | $26.9K | 9,892 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,424,242 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,063,107 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | C Conversion deriv | 2015-10-13 | 2015-10-13 | 2,000,000 | — | $0 | 0 | SEC↗ |